Clinical Research Directory
Browse clinical research sites, groups, and studies.
Refusal of Sentinel Lymph Node Biopsy in Patients With Luminal A Subtype Early Breast Cancer
Sponsor: N.N. Petrov National Medical Research Center of Oncology
Summary
Sentinel lymph node biopsy (SLNB) is the standard of axillary lymph node surgical staging in patients with early breast cancer. The main goal of the study is to abandon axillary surgery in patients over 59 years old with early, luminal A, clinical lymph node negative breast cancer.
Key Details
Gender
FEMALE
Age Range
60 Years - Any
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2023-07-27
Completion Date
2027-05-25
Last Updated
2026-05-12
Healthy Volunteers
No
Conditions
Interventions
breast resection
breast resection without sentinel lymph node biopsy, radiotherapy to the breast area and sentinel lymph nodes
Breast resection with sentinel lymph node biopsy
Breast resection with sentinel lymph node biopsy, radiotherapy to the breast and axilla according to current treatment standards
Locations (1)
N.N. Petrov National Medical Research Center of Oncology
Saint Petersburg, Russian Federation, Russia